(Q36534770)

14 August 2017

1 reference

title

Hepatocyte growth factor: new arsenal in the fights against renal fibrosis? (English)

1 reference

14 August 2017

Liu Y

1

1 reference

PubMed ID

16838037

14 August 2017

Yang J

series ordinal

2

1 reference

PubMed ID

16838037

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

14 August 2017

1 reference

14 August 2017

70

1 reference

14 August 2017

2

1 reference

14 August 2017

238-240

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001661

14 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Hepatocyte growth factor: a regulator of extracellular matrix genes in mouse mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Suppressions of chronic glomerular injuries and TGF-β1production by HGF in attenuation of murine diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001661

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001661

1 reference

14 August 2017

1 reference

PubMed ID

16838037